Public Company News

Antengene Highlights Encouraging ATG-008 Efficacy Results From TORCH-2 Study in Combination with PD-1 Antibody in Relapsed/Metastatic Cervical Cancer

* An objective response rate (ORR) of 52.4% was observed in relapsed or metastatic cervical cancer in Phase I/II TORCH-2 Study of ATG-008 (onatasertib) in combination with toripalimab, regardless of PD-L1 status * Study builds on promising results of Phase II TORCH monotherapy study in HBV+ p...

2022-11-15 16:51 3000

Veoneer Awarded Active Safety System by Major Asian OEM

STOCKHOLM, Nov. 15, 2022 /PRNewswire/ -- The automotive technology company Veoneer has signed an agreement with a major Asian OEM to equip an electric vehicle joint-venture inChina with an active safety system comprising of a monovision camera, a package of forward-looking and corner radars, and ...

2022-11-15 16:23 2692

Yili wins the 2022 Global Water Drinks Award

EVIAN-LES-BAINS, France, Nov. 15, 2022 /PRNewswire/ -- The 19th Global Water Drinks Congress was held in Évian-les-Bains,France, from November 8 to 10. Yili's Inikin mineral water won the 2022 Global Water Drinks Award. Dr.Gerrit Smit, Managing Director of the Yili Innovation Center Europe, atten...

2022-11-15 16:18 5361

Clarivate Names World's Influential Researchers with Highly Cited Researchers 2022 List

Institute for Scientific Information deepens qualitative analysis of annual list to improve detection of gaming, misconduct LONDON, Nov. 15, 2022 /PRNewswire/ -- Clarivate Plc (NYSE: CLVT), a global leader in providing trusted information and insights to accelerate the pace of innovation, today ...

2022-11-15 16:02 2658

XCA 2600, World's Strongest All-Terrain Crane Developed by XCMG, Sets New Wind Power Hoisting Record

WEIFANG, China, Nov. 15, 2022 /PRNewswire/ -- XCA2600, the world's strongest all-terrain crane independently developed by XCMG (SHE: 000425), world top three construction machinery manufacturer, lifted and installed an 8.5MW wind turbine recently in the Changyi Wind Farm in Weifang,Shandong Provi...

2022-11-15 14:28 3989

Gamma Selects Dubber for Intelligent Recording on Microsoft Teams

* Gamma launches Dubber intelligent call recording and Dubber AI, enabling partners and customers to unlock the value in voice * Dubber is the exclusive vendor for MiFID II compliant call recording on Microsoft Teams via Gamma partners * Available across Gamma's Microsoft Teams voice enablem...

2022-11-15 13:05 3564

Sushma Panchawati Joins Stagwell's (STGW) National Research Group as Senior Vice President as the Firm Expands its Asia-Pacific Footprint

 Panchawati has joined the Content and Strategy leadership team and will be based inSingapore NEW YORK and SINGAPORE, Nov. 15, 2022 /PRNewswire/ -- National Research Group (NRG), recognized as an insights leader at the edge of technology, content, and culture, today announced that Sushma Panchaw...

2022-11-15 12:47 5340

Xref (ASX:XF1) launches 'Trust Marketplace' to help employers rapidly & safely recruit in global staffing crisis

SYDNEY, Nov. 15, 2022 /PRNewswire/ -- Global HR tech platform Xref  (ASX:XF1) has officially launchedAustralia's first fully agnostic, API-only marketp...

2022-11-15 10:10 3633

SEMBCORP LAUNCHES NEW CARBON MANAGEMENT SOLUTIONS CORPORATE VENTURE, GONETZERO™

-       Collaborations with OCBC, Razer and UBS to drive decarbonisation initiatives SINGAPORE, Nov. 15, 2022 /PRNewswire/ -- Sembcorp Industries (Sembcorp) will be launching its carbon management solutions corporate venture, GoNetZero™, today at the Singapore Pavilion at the 27th United Nations...

2022-11-15 08:54 4091

Everest Medicines Announces New Drug Application Acceptance by China NMPA for Nefecon for the Treatment of Primary IgA Nephropathy

-- NDA acceptance takes Everest closer to making this first-in-disease treatment available for primary IgAN patients inChina -- China is home to the largest patient base for IgAN with estimated 5 million people with the disease and currently there is no approved treatment in the country -- Nefe...

2022-11-15 08:00 5148

Innovent Announces First Participant Dosed in a Phase 3 Clinical Study (GLORY-1) of Mazdutide (IBI362) in Chinese Adults with Overweight or Obesity

ROCKVILLE, Md. and SUZHOU, China, Nov. 15, 2022 /PRNewswire/ -- Innovent Biologics, Inc. (Innovent) (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes high-quality medicines for the treatment of oncology, metabolic, autoimmune, ophthalmology and ...

2022-11-15 08:00 4945

Maytronics to introduce at Piscine Global 2022 the Dolphin LIBERTY(TM) line

The Dolphin LIBERTY™ line is the new generation of cordless robotic pool cleaning with revolutionary new technologies for increased efficiency and ease of use KIBBUTZ YIZREEL, Israel, Nov. 15, 2022 /PRNewswire/ -- Maytronics (TASE: MTRN), the global leader in robotic pool cleaners, will introduc...

2022-11-15 05:00 3593

LumiraDx Continues Commercial Expansion of its Rapid Microfluidic Immunoassay HbA1c Test

Now Available in Europe, parts of the Middle East, Asia, Latin America, and Africa  * Early customers include GP offices and other community-based healthcare settings * Latest figures, released as part of World Diabetes Day, reveal that 1 in 10 adults are now living with diabetes and nearly ...

2022-11-14 23:24 3495

Wolters Kluwer CCH® Tagetik expands its APAC footprint to serve a growing South Korean client base and strong demand for Corporate Performance Management Solutions

South Korea presence will enhance its regional footprint to 11 countries; industry veteran to lead new operation NEW YORK, Nov. 14, 2022 /PRNewswire/ -- Wolters Kluwer  (AEX: WKL), a leading global provider of expert solutions, insights, and services for profess...

2022-11-14 23:00 4862

GGE announces the appointment of a CEO of its US Subsidiary to lead the effort to explore green energy sector

HANZHONG, China, Nov. 14, 2022 /PRNewswire/ -- Green Giant Inc. (NASDAQ: GGE) ("GGE" or the "Company"), today announced appointment of Mr.Junaid Ali as CEO of its wholly owned subsidiary Green Giant LLC to spearhead its effort to explore green energy section in the U.S. Mr. Junaid Ali has decade...

2022-11-14 22:35 6182

Appier reports another profitable quarter with record high revenue growth and gross margin

Full-year forecast revised up for the third quarter in a row, marking the company's strong business momentum and optimistic outlook ahead TAIPEI, Nov. 14, 2022 /PRNewswire/ -- Highlights and achievements for the third quarter of fiscal year 2022 * Revenue increased to 5.1 billion yen with the ...

2022-11-14 21:39 3926

Hyundai Motor Group Signs MoU with Nusantara Capital City Authority to Establish Ecosystem for Advanced Air Mobility

-  A First Step to Open Up AAM in ASEAN Market  - * President Jaiwon Shin of Hyundai Motor Group and the Head of Nusantra Capital City AuthorityBambang Susantono attended the MoU signing ceremony * The Group and local authorities signed to proactively introduce advanced air mobility (AAM) in ...

2022-11-14 21:29 3414

CBTS Deploys Ribbon Connect to Accelerate Operator Connect for Microsoft Teams Implementation

Turnkey solution facilitates delivery of Operator Connect for Microsoft Teams, spurring deployment of hybrid work environments PLANO, Texas, Nov. 14, 2022 /PRNewswire/ -- Ribbon Communications Inc. (Nasdaq: RBBN), a global provider of real time communications technology and IP optical networking...

2022-11-14 21:00 3069

Hyundai Motor Group Executive Chair Urges Bold Action on Climate Change and Energy Poverty at B20 Summit Indonesia 2022

* Executive Chair Euisun Chung speaks on the topic of 'Energy Poverty and Accelerate a Just and Orderly Sustainable Energy Use,' at B20 Summit Indonesia 2022 * Occurring prior to G20 Summit, the B20 Summit attracts thousands of attendees from major G20 member countries * Executive Chair Chu...

2022-11-14 20:29 3001

RedHill Accelerates Opaganib's Nuclear Radiation Protection Program - Positive Data Published

Strong preclinical data, recently published in the International Journal of Molecular Sciences, from eight U.S government-funded in-vivo opaganib studies, supports opaganib's potential as a nuclear radiation injury therapeutic for homeland security material threat medical countermeasures (MCM) an...

2022-11-14 20:06 3894
1 ... 723724725726727728729 ... 904